Satellos Bioscience Inc (MSCL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 14 | 5 | 248 | 130 | 0 |
| Accounts receivable | -30 | -243 | 197 | -53 | 200 |
| Other Working Capital | -714 | 278 | 731 | -381 | -143 |
| Other Operating Activity | -16,672 | -10,971 | -5,386 | -3,644 | -1,359 |
| Operating Cash Flow | $-17,402 | $-10,931 | $-4,210 | $-3,948 | $-1,302 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -14 | -3 | -6 | 0 |
| Purchase Of Investment | -26,015 | -13,207 | N/A | N/A | N/A |
| Sale Of Investment | 30,435 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 1,369 | 0 |
| Investing Cash Flow | $4,416 | $-13,220 | $-3 | $1,363 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 1,692 | 0 | 146 | 853 |
| Debt Repayment | 0 | -1,906 | N/A | N/A | N/A |
| Common Stock Issued | 29,823 | 24,471 | 1,471 | 5,552 | 698 |
| Other Financing Activity | 7,444 | 14,212 | 574 | 145 | 0 |
| Financing Cash Flow | $37,267 | $38,469 | $2,045 | $5,844 | $1,551 |
| Exchange Rate Effect | 518 | 866 | -4 | -1 | 0 |
| Beginning Cash Position | 15,376 | 1,450 | 3,589 | 563 | 313 |
| End Cash Position | 40,175 | 16,634 | 1,417 | 3,821 | 563 |
| Net Cash Flow | $24,281 | $14,318 | $-2,168 | $3,259 | $250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,402 | -10,931 | -4,210 | -3,948 | -1,302 |
| Capital Expenditure | -4 | -14 | -3 | -6 | N/A |
| Free Cash Flow | -17,406 | -10,945 | -4,212 | -3,954 | -1,302 |